William D. Claypool
Vorstandsvorsitzender bei Hsiri Therapeutics, Inc.
Profil
William D.
Claypool was the founder of Pennmark Associates LLC, founded in 2008, where he held the title of Senior Partner.
He is also the founder of Ranedis Pharmaceuticals.
Currently, he is the President & Chief Executive Officer at Hsiri Therapeutics, Inc. since 2012 and a Director at NP-C Therapeutics LLC.
He previously held positions such as President & Chief Executive Officer at The Gi Co., Inc. in 2001, Director at Shire ViroPharma, Inc. from 2003 to 2012, Director at 3-Dimensional Pharmaceuticals, Inc. in 2003, Director at Morphotek, Inc. from 2005 to 2007, Independent Director at Cipher Pharmaceuticals, Inc. from 2009 to 2016, and President at Phoenix Data Systems, Inc. in 2008.
Dr. Claypool received his undergraduate degree from the University of Notre Dame and his doctorate from The University of Connecticut School of Medicine.
Aktive Positionen von William D. Claypool
| Unternehmen | Position | Beginn |
|---|---|---|
Hsiri Therapeutics, Inc.
 Hsiri Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Hsiri Therapeutics LLC engages in the discovering and developing therapies for infections due to drug resistant bacteria. Its research efforts are focuses on two major areas including infections due to mycobacteria and infections due to usual bacterial pathogens. The firm also developing compounds aimed at traditional bacterial infections caused by drug resistant bacteria. The company was founded by Dennis F. Willson and is headquartered in Media, PA. | Vorstandsvorsitzender | 01.01.2012 |
NP-C Therapeutics LLC
 NP-C Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services NP-C Therapeutics LLC develops pharmaceutical products for treatment of Niemann-Pick Type C disease. The company was incorporated in 2014 and is headquartered in King of Prussia, PA. | Direktor/Vorstandsmitglied | - |
Ranedis Pharmaceuticals
 Ranedis Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ranedis Pharmaceuticals operates as a biopharmaceutical company. The company was founded by William Claypool and Denny Willson and is headquartered in Media, PA. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von William D. Claypool
| Unternehmen | Position | Ende |
|---|---|---|
| CIPHER PHARMACEUTICALS INC. | Direktor/Vorstandsmitglied | 09.08.2016 |
Phoenix Data Systems, Inc.
 Phoenix Data Systems, Inc. Information Technology ServicesTechnology Services Phoenix Data Systems, Inc. provides electronic data capture and data management services for the pharmaceutical industries. Its services include reporting, training, and coding. The company was founded in 1997 and is headquartered in King of Prussia, PA. | Präsident | 01.03.2008 |
Morphotek, Inc.
 Morphotek, Inc. Miscellaneous Commercial ServicesCommercial Services Morphotek, Inc. operates as a biotechnology company. It develops and distributes biopharmaceutical products. The firm leverages its Morphodoma and Libradoma platform technologies to develop and research a pipeline of preclinical and clinical stage monoclonal antibodies for the treatment of cancer, inflammation and infectious diseases. The company was founded by Nicholas C. Nicolaides, Luigi Grasso and Philip M. Sass in May 2000 and is headquartered in Exton, PA. | Direktor/Vorstandsmitglied | 01.04.2007 |
3-Dimensional Pharmaceuticals, Inc.
 3-Dimensional Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology 3-Dimensional Pharmaceuticals, Inc. was acquired by Johnson & Johnson. 3-Dimensional Pharmaceuticals, Inc. operates as a drug discovery and development company that has a pipeline of drug candidates in the areas of cancer and inflammation, and metabolic and cardiovascular diseases | Direktor/Vorstandsmitglied | 01.04.2003 |
The Gi Co., Inc.
 The Gi Co., Inc. Pharmaceuticals: OtherHealth Technology The Gi Company Inc. develops drugs to treat gastrointestinal and related diseases. It offers intestinal trefoil factor for the treatment of oral mucositis. The company also has projects in enteritis, proctitis, inflammatory bowel disease, erosive gastro esophageal reflux disease, peptic ulcer disease and gastrointestinal motility disorders, as well as clinical programs in erosive gastritis, ulcerative colitis and corneal wound healing. The company was founded in 1998 and is headquartered in Framingham, MA. | Präsident | 01.06.2001 |
Ausbildung von William D. Claypool
| University of Notre Dame | Undergraduate Degree |
| The University of Connecticut School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CIPHER PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 10 |
|---|---|
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Health Technology |
3-Dimensional Pharmaceuticals, Inc.
3-Dimensional Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology 3-Dimensional Pharmaceuticals, Inc. was acquired by Johnson & Johnson. 3-Dimensional Pharmaceuticals, Inc. operates as a drug discovery and development company that has a pipeline of drug candidates in the areas of cancer and inflammation, and metabolic and cardiovascular diseases | Health Technology |
Morphotek, Inc.
Morphotek, Inc. Miscellaneous Commercial ServicesCommercial Services Morphotek, Inc. operates as a biotechnology company. It develops and distributes biopharmaceutical products. The firm leverages its Morphodoma and Libradoma platform technologies to develop and research a pipeline of preclinical and clinical stage monoclonal antibodies for the treatment of cancer, inflammation and infectious diseases. The company was founded by Nicholas C. Nicolaides, Luigi Grasso and Philip M. Sass in May 2000 and is headquartered in Exton, PA. | Commercial Services |
Phoenix Data Systems, Inc.
Phoenix Data Systems, Inc. Information Technology ServicesTechnology Services Phoenix Data Systems, Inc. provides electronic data capture and data management services for the pharmaceutical industries. Its services include reporting, training, and coding. The company was founded in 1997 and is headquartered in King of Prussia, PA. | Technology Services |
| Smithkline Beecham Pharmaceuticals (India) Ltd. | Health Technology |
The Gi Co., Inc.
The Gi Co., Inc. Pharmaceuticals: OtherHealth Technology The Gi Company Inc. develops drugs to treat gastrointestinal and related diseases. It offers intestinal trefoil factor for the treatment of oral mucositis. The company also has projects in enteritis, proctitis, inflammatory bowel disease, erosive gastro esophageal reflux disease, peptic ulcer disease and gastrointestinal motility disorders, as well as clinical programs in erosive gastritis, ulcerative colitis and corneal wound healing. The company was founded in 1998 and is headquartered in Framingham, MA. | Health Technology |
Pennmark Associates LLC
 Pennmark Associates LLC Medical DistributorsDistribution Services Pennmark Associates LLC engaged in wholesaling pharmaceutical products. The company was headquartered in Wayne, PA. | Distribution Services |
Hsiri Therapeutics, Inc.
Hsiri Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Hsiri Therapeutics LLC engages in the discovering and developing therapies for infections due to drug resistant bacteria. Its research efforts are focuses on two major areas including infections due to mycobacteria and infections due to usual bacterial pathogens. The firm also developing compounds aimed at traditional bacterial infections caused by drug resistant bacteria. The company was founded by Dennis F. Willson and is headquartered in Media, PA. | Commercial Services |
NP-C Therapeutics LLC
NP-C Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services NP-C Therapeutics LLC develops pharmaceutical products for treatment of Niemann-Pick Type C disease. The company was incorporated in 2014 and is headquartered in King of Prussia, PA. | Commercial Services |
Ranedis Pharmaceuticals
Ranedis Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ranedis Pharmaceuticals operates as a biopharmaceutical company. The company was founded by William Claypool and Denny Willson and is headquartered in Media, PA. | Commercial Services |
